Stocks/ABL

ABL three-lens brief

Evidence-based stock research on ABL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 08:00 ET
$5.00$9.53$12.44

Performance

1W
-2.3%
1M
+0.1%
3M
6M
YTD
1Y
3Y
5Y
ABL · Nightly brief
Inspect

Underperforming SPY by 11.4pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.

  • Trading >3% below the 50-day MA — short-term weakness.
  • Underperforming SPY by 11.4pp over 30 days.
  • P/E of 169 — priced for high growth; little margin of safety.

ABL closed at $9.53 (-0.94%) as of 2026-09-11. Market cap: $931.58M. P/E (trailing) 169.4. Price is below the 50-day MA and above the 200-day MA. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 11.4pp over 30 days..

Market ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on ABL, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ABLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/ABL"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ABL brief"></iframe>